SCHEMBL548162

SCHEMBL548162

O=C(O)C1=Nc2cccc3cc4ccccc4c(c23)N1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.42
KMT2A Q03164 8/20 0.42
KDM4E B2RXH2 6/20 0.42
ALDH1A1 P00352 4/20 0.42
HSD17B10 Q99714 3/20 0.42
CYP1A2 P05177 2/20 0.42
HPGD P15428 2/20 0.42
GLA P06280 1/20 0.42
CYP2C19 P33261 1/20 0.42
MAPT P10636 3/20 0.38
NPC1 O15118 3/20 0.38
RAB9A P51151 3/20 0.38
GAA P10253 3/20 0.38
MAPK1 P28482 1/20 0.38
STAT3 P40763 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
NR4A1 P22736 1/20 0.36
NR4A2 P43354 1/20 0.36
NR4A3 Q92570 1/20 0.36
LMNA P02545 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5337037 0.73 KMT2A (0.56) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL29709862 0.73 KMT2A (0.56) MEN1KMT2AKDM4EALDH1A1CYP1A2
SCHEMBL634465 0.67 GRK6 (0.50) MEN1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL27778818 0.65 NR4A1 (0.56) MEN1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL69796 0.62 ALDH1A1 (0.67) MEN1KMT2AKDM4EALDH1A1HSD17B10
Anthracene-9-Carboxylic Acid SCHEMBL122832 0.62 MEN1 (1.00) MEN1KMT2AKDM4EALDH1A1HSD17B10
Anthracene-9-Carboxylic Acid SCHEMBL29352186 0.62 MEN1 (1.00) MEN1KMT2AKDM4EALDH1A1HSD17B10
Hydrochloric Acid SCHEMBL8854745 0.61 ALDH1A1 (0.65) MEN1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL7054297 0.61 KMT2A (0.65) MEN1KMT2AKDM4EALDH1A1HSD17B10
SCHEMBL27668321 0.61 MEN1 (0.65) MEN1KMT2AKDM4EALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 63 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385476-B1 COMPOSITION FOR TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS CEDARS SINAI MEDICAL CENTER (US) 2021-01-27 EP disclosed
EP-2305213-B1 The treatment of small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions CEDARS SINAI MEDICAL CENTER (US) 2017-06-28 EP disclosed
US-20170095543-A1 METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS CEDARS-SINAI MEDICAL CENTER (US) 2017-04-06 US disclosed
EP-2267445-B1 Methods of detecting small intestinal bacterial overgrowth (SIBO) in a human subject CEDARS SINAI MEDICAL CENTER (US) 2016-08-17 EP disclosed
US-9358276-B2 Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions CEDARS-SINAI MEDICAL CENTER (US) 2016-06-07 US disclosed
US-20150306190-A1 METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS CEDARS-SINAI MEDICAL CENTER (US) 2015-10-29 US disclosed
EP-2261664-B1 Methods of treating bloating, abdominal pain and diarrhea CEDARS SINAI MEDICAL CENTER (US) 2015-07-01 EP disclosed
EP-2256498-B1 Methods of diagnosing or treating irritable bowel syndrome and other disorders CEDARS SINAI MEDICAL CENTER (US) 2015-04-08 EP disclosed
US-20140206636-A1 METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS CEDARS-SINAI MEDICAL CENTER (US) 2014-07-24 US disclosed
EP-2261665-B1 Methods of diagnosing Crohn's disease CEDARS SINAI MEDICAL CENTER (US) 2014-06-25 EP disclosed
US-6562629-B1 Diagnosing small intestinal bacterial ammplified propagation od disorders caused by amplified propagation; obtain serum sample, incubate with antibody, detect signal from bound antibody, signal from bound antibody indicates disorder CEDARS-SINAI MEDICAL CENTER 2003-05-13 US disclosed
US-20030031625-A1 Methods of diagnosing irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth LIN HENRY C (US) 2003-02-13 US disclosed
WO-2002083926-A2 METHODS OF DIAGNOSING AND TREATING SMALL INTESTINAL BACTERIAL OVERGROWTH (SIBO) AND SIBO-RELATED CONDITIONS CEDARS-SINAI MEDICAL CENTER (US) 2002-10-24 WO disclosed
EP-1200828-A2 METHODS OF DIAGNOSING AND TREATING IRRITABLE BOWEL SYNDROME AND OTHER DISORDERS Cedars-Sinai Medical Center (US) 2002-05-02 EP disclosed
US-20020039599-A1 Calibration; administering antiseptic compound NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2002-04-04 US disclosed
WO-2001011077-A9 METHODS OF DIAGNOSING OR TREATING IRRITABLE BOWEL SYNDROME AND OTHER DISORDERS CEDARS SINAI MEDICAL CENTER (US) 2001-09-20 WO disclosed
WO-2001011334-A2 METHOD OF DIAGNOSING IRRITABLE BOWEL SYNDROME AND OTHER DISEASES BY DETECTING ANTI-SACCHAROMYCES CEREVISIAE ANTIBODY CEDARS-SINAI MEDICAL CENTER (US) 2001-02-15 WO disclosed
WO-2001011077-A2 METHODS OF DIAGNOSING OR TREATING IRRITABLE BOWEL SYNDROME AND OTHER DISORDERS CEDARS-SINAI MEDICAL CENTER (US) 2001-02-15 WO disclosed
US-5861398-A Benzoperimidine-carboxylic acids and derivatives thereof ALANEX CORPORATION (US) 1999-01-19 US disclosed
WO-1998008821-A1 BENZOPERIMIDINE-CARBOXYLIC ACIDS AND DERIVATIVES THEREOF AGOURON ACQUISITION CORP. (US) 1998-03-05 WO disclosed